Literature DB >> 10553048

Autoimmune myocarditis does not require B cells for antigen presentation.

S Malkiel1, S Factor, B Diamond.   

Abstract

T cells constitute the pathogenic effector cell population in autoimmune myocarditis in BALB/c mice. Using mice rendered deficient for B cells by a targeted disruption to the IgM transmembrane domain or by treatment with anti-IgM Ab from birth, we asked whether B cells are a critical APC in the induction of autoimmune myocarditis. B cell-deficient mice immunized with cardiac myosin develop myocarditis comparable in incidence and severity to that in wild-type mice, suggesting that autoreactive T cells that cause myocarditis in BALB/c mice are activated by macrophages or dendritic cells. Since it does not appear that presentation of cryptic epitopes is critical for the breakdown of self tolerance, potentially pathogenic T cells recognizing dominant myosin epitopes must have escaped tolerization. Either anatomic sequestration of cardiac myosin peptide-MHC complexes or subthreshold presentation of cardiac myosin peptides by conventional APC can explain the survival of these autoreactive T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553048

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  A locus on chromosome 1 promotes susceptibility of experimental autoimmune myocarditis and lymphocyte cell death.

Authors:  Davinna L Ligons; Mehmet L Guler; Haiyan S Li; Noel R Rose
Journal:  Clin Immunol       Date:  2008-10-31       Impact factor: 3.969

2.  Immunohistological analyses of myocardial infiltrating cells in various animal models of myocarditis.

Authors:  Zuyi Yuan; Keisuke Shioji; Chiharu Kishimoto
Journal:  Exp Clin Cardiol       Date:  2003

3.  Genetic differences in bone marrow-derived lymphoid lineages control susceptibility to experimental autoimmune myocarditis.

Authors:  Haiyan S Li; Davinna L Ligons; Noel R Rose; Mehmet L Guler
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

4.  Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis.

Authors:  Thomas J Bahk; Melvin D Daniels; Juan S Leon; Kegiang Wang; David M Engman
Journal:  Int J Cardiol       Date:  2007-06-22       Impact factor: 4.164

5.  Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune response.

Authors:  Jillian A Fontes; Jobert G Barin; Monica V Talor; Natalie Stickel; Julie Schaub; Noel R Rose; Daniela Čiháková
Journal:  Immun Inflamm Dis       Date:  2017-03-13

6.  Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy.

Authors:  Nicola L Diny; G Christian Baldeviano; Monica V Talor; Jobert G Barin; SuFey Ong; Djahida Bedja; Allison G Hays; Nisha A Gilotra; Isabelle Coppens; Noel R Rose; Daniela Čiháková
Journal:  J Exp Med       Date:  2017-03-16       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.